Paper20009104
EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy.
Guo D and 25 others. Sci Signal, 2009. Cited by 298 papers, by iCite.
Cite this record
ConductScience Library. EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy. Papers, record 20009104. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20009104
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Brain Neoplasms | Major topic |
| ErbB Receptors | Major topic |
| Glioblastoma | Major topic |
| Lipogenesis | Major topic |
| Proto-Oncogene Proteins c-akt | Major topic |
| Quinazolines | Major topic |
| Signal Transduction | Major topic |
| Sirolimus | Major topic |
| Sterol Regulatory Element Binding Protein 1 | Major topic |
| Fatty Acids | |
| Gene Knockdown Techniques | |
| Humans | |
| Hydrolysis | |
| Lapatinib | |
| Phosphatidylinositol 3-Kinases | |
| Protein Transport |
Source PubMed
Grants25
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA108633 | NCI NIH HHS | United States | R01CA108633 | PubMed and NIH | NIH RePORTER |
| M01-RR03186 | NCRR NIH HHS | United States | M01RR003186 | PubMed and NIH | NIH RePORTER |
| R01 NS050151 | NINDS NIH HHS | United States | R01NS050151 | PubMed and NIH | NIH RePORTER |
| P30CA54174 | NCI NIH HHS | United States | P30CA054174 | PubMed and NIH | NIH RePORTER |
| NS050151 | NINDS NIH HHS | United States | R01NS050151 | PubMed and NIH | NIH RePORTER |
| CA16672 | NCI NIH HHS | United States | P01CA016672 | PubMed and NIH | NIH RePORTER |
| U54 CA119347 | NCI NIH HHS | United States | U54CA119347 | PubMed and NIH | NIH RePORTER |
| U01 CA062399 | NCI NIH HHS | United States | U01CA062399 | PubMed and NIH | NIH RePORTER |
| U01 CA062421 | NCI NIH HHS | United States | U01CA062421 | PubMed and NIH | NIH RePORTER |
| U01 CA062422 | NCI NIH HHS | United States | U01CA062422 | PubMed and NIH | NIH RePORTER |
| CA62412 | NCI NIH HHS | United States | U01CA062412 | PubMed and NIH | NIH RePORTER |
| U01 CA062407 | NCI NIH HHS | United States | U01CA062407 | PubMed and NIH | NIH RePORTER |
| U01 CA062426 | NCI NIH HHS | United States | U01CA062426 | PubMed and NIH | NIH RePORTER |
| M01 RR000079 | NCRR NIH HHS | United States | M01RR000079 | PubMed and NIH | NIH RePORTER |
| M01 RR000056 | NCRR NIH HHS | United States | M01RR000056 | PubMed and NIH | NIH RePORTER |
| M01-RR00079 | NCRR NIH HHS | United States | M01RR000079 | PubMed and NIH | NIH RePORTER |
| R01 CA108633 | NCI NIH HHS | United States | R01CA108633 | PubMed and NIH | NIH RePORTER |
| U01CA62422 | NCI NIH HHS | United States | U01CA062422 | PubMed and NIH | NIH RePORTER |
| M01-RR00056 | NCRR NIH HHS | United States | M01RR000056 | PubMed and NIH | NIH RePORTER |
| CA 62404 | NCI NIH HHS | United States | PubMed | PubMed |
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18455118 | A sweet new role for EGFR in cancer. | Cancer Cell | 2008 | https://conductscience.org/library/papers/18455118 | PubMed |
| 2 | 18215105 | Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma. | PLoS Med | 2008 | https://conductscience.org/library/papers/18215105 | PubMed |
| 3 | 8895767 | A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis. | Cancer Res | 1996 | https://conductscience.org/library/papers/8895767 | PubMed |
| 4 | 17872411 | Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies. | Science | 2007 | https://conductscience.org/library/papers/17872411 | PubMed |
| 5 | 15956649 | Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib. | J Natl Cancer Inst | 2005 | https://conductscience.org/library/papers/15956649 | PubMed |
| 6 | 18325754 | Acquired resistance to tyrosine kinase inhibitors during cancer therapy. | Curr Opin Genet Dev | 2008 | https://conductscience.org/library/papers/18325754 | PubMed |
| 7 | 14638850 | Phase II trial of gefitinib in recurrent glioblastoma. | J Clin Oncol | 2004 | https://conductscience.org/library/papers/14638850 | PubMed |
| 8 | 18568074 | Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins. | J Clin Invest | 2008 | https://conductscience.org/library/papers/18568074 | PubMed |
| 9 | 12782577 | Analysis of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma patients in vivo. | Cancer Res | 2003 | https://conductscience.org/library/papers/12782577 | PubMed |
| 10 | 18772890 | Comprehensive genomic characterization defines human glioblastoma genes and core pathways. | Nature | 2008 | https://conductscience.org/library/papers/18772890 | PubMed |
| 11 | 16282176 | Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. | N Engl J Med | 2005 | https://conductscience.org/library/papers/16282176 | PubMed |
| 12 | 18382725 | From fatty streak to fatty liver: 33 years of joint publications in the JCI. | J Clin Invest | 2008 | https://conductscience.org/library/papers/18382725 | PubMed |
| 13 | 15758009 | Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. | N Engl J Med | 2005 | https://conductscience.org/library/papers/15758009 | PubMed |
| 14 | 9235933 | Coordinate regulation of lipogenesis, the assembly and secretion of apolipoprotein B-containing lipoproteins by sterol response element binding protein 1. | J Biol Chem | 1997 | https://conductscience.org/library/papers/9235933 | PubMed |
| 15 | 17046224 | Glucose metabolism and cancer. | Curr Opin Cell Biol | 2006 | https://conductscience.org/library/papers/17046224 | PubMed |
| 16 | 7958866 | Sterol-resistant transcription in CHO cells caused by gene rearrangement that truncates SREBP-2. | Genes Dev | 1994 | https://conductscience.org/library/papers/7958866 | PubMed |
| 17 | 18177721 | The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. | Cell Metab | 2008 | https://conductscience.org/library/papers/18177721 | PubMed |
| 18 | 11057895 | Cell signaling by receptor tyrosine kinases. | Cell | 2000 | https://conductscience.org/library/papers/11057895 | PubMed |
| 19 | 19625624 | The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19625624 | PubMed |
| 20 | 18455122 | Survival of cancer cells is maintained by EGFR independent of its kinase activity. | Cancer Cell | 2008 | https://conductscience.org/library/papers/18455122 | PubMed |
Cited by235
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 298 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42958602 | Glioblastoma as a dynamic tumor ecosystem: from molecular alterations to therapeutic translation. | Exp Hematol Oncol | 2026 | https://conductscience.org/library/papers/42958602 | PubMed |
| 42942857 | BH3 Profiling Identifies Apoptotic Priming by SREBP-1/-2 Inhibition and Synergistic Anti-Glioblastoma Activity When Combined with ABT-263 In Vitro. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42942857 | PubMed |
| 42649887 | Fatty Acid Metabolism Rewires Glioblastoma Progression and Treg-Mediated Immune Resistance. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42649887 | PubMed |
| 42613451 | The interplay between lipid metabolism, cancer progression and anti-cancer immunity. | Exp Mol Med | 2026 | https://conductscience.org/library/papers/42613451 | PubMed |
| 42220493 | Comprehensive analysis of fatty acid desaturase 3 in clear cell renal cell carcinoma: insights into tumor progression, immune microenvironment, and clinical outcomes. | Front Immunol | 2026 | https://conductscience.org/library/papers/42220493 | PubMed |
| 42009969 | Thr3/Ser90 phosphorylation-stabilized S100A8 regulates cholesterol metabolism in glioblastoma stem cells. | Oncogene | 2026 | https://conductscience.org/library/papers/42009969 | PubMed |
| 41971814 | Targeting fatty acid metabolism for cancer therapy. | Fundam Res | 2026 | https://conductscience.org/library/papers/41971814 | PubMed |
| 41838210 | GPR40 Attenuates Glioma TMZ-Resistance Through Ferroptosis Inhibition. | Neurochem Res | 2026 | https://conductscience.org/library/papers/41838210 | PubMed |
| 41820632 | Metabolic dependencies and neural progenitor dysregulation: driving forces in paediatric high-grade glioma development. | Cancer Metastasis Rev | 2026 | https://conductscience.org/library/papers/41820632 | PubMed |
| 41732157 | Clinical significance and oncogenic role of ECHDC2 in glioblastoma: a comprehensive analysis based on bioinformatics and in vitro experiments. | Front Genet | 2026 | https://conductscience.org/library/papers/41732157 | PubMed |
| 41663272 | Metabolic permissiveness: how tissue context shapes cancer. | Genes Dev | 2026 | https://conductscience.org/library/papers/41663272 | PubMed |
| 41569525 | Lipids regulate epidermal growth factor receptor activation by its ligands. | Biochem Soc Trans | 2026 | https://conductscience.org/library/papers/41569525 | PubMed |
| 41057350 | Cut the fat: targeting cholesterol and lipid metabolism in glioblastoma. | Cell Death Dis | 2025 | https://conductscience.org/library/papers/41057350 | PubMed |
| 40931220 | Exploring Differentially Expressed Genes and Understanding the Underlying Mechanisms in Glioblastoma. | Biochem Genet | 2026 | https://conductscience.org/library/papers/40931220 | PubMed |
| 40855015 | BRI3 Orchestrates Lipid Metabolism and Autophagy in Glioblastoma: Implications for Tumor Cell Resilience. | Biochem Genet | 2026 | https://conductscience.org/library/papers/40855015 | PubMed |
| 40814339 | Palmitic acid and palmitoylation in cancer: Understanding, insights, and challenges. | Innovation (Camb) | 2025 | https://conductscience.org/library/papers/40814339 | PubMed |
| 40628732 | Glioblastoma at the crossroads: current understanding and future therapeutic horizons. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/40628732 | PubMed |
| 40539068 | Targeting metabolic reprogramming to overcome immune tolerance in melanoma immunotherapy. | Front Immunol | 2025 | https://conductscience.org/library/papers/40539068 | PubMed |
| 40454501 | Metabolic Targets in CRC: The Emerging Role of Cytochrome P450 Inhibitors. | Curr Pharm Des | 2025 | https://conductscience.org/library/papers/40454501 | PubMed |
| 40249802 | Targeting PGM3 abolishes SREBP-1 activation-hexosamine synthesis feedback regulation to effectively suppress brain tumor growth. | Sci Adv | 2025 | https://conductscience.org/library/papers/40249802 | PubMed |
Genes15
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20009104
GET https://conductscience.org/api/papers/v1/20009104/authors?page=2